申请人:ImmunoMolecular Therapeutics, INC.
公开号:US11052060B2
公开(公告)日:2021-07-06
Compounds and compositions useful in methods of treating, ameliorating, or inhibiting the development of autoimmune diseases or Celiac disease by modulating the binding of DQ8 MHC class II molecules to antigenic peptides or fragments of antigenic peptides.
通过调节 DQ8 MHC II 类分子与抗原肽或抗原肽片段的结合,用于治疗、改善或抑制自身免疫性疾病或乳糜泻发展的化合物和组合物。